Skip to main content

US ClosedU.S. Closed

CRDF: Cardiff Oncology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Cardiff Oncology, Inc. , a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States.

52W Range

7thpctl

Volume

0.41×avg

Market Cap

72.45MUSD

P/E Ratio

-1.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Cardiff Oncology, Inc.

CRDFNASDAQ·USD·Closed

Cardiff Oncology, Inc.

CRDFNASDAQ·USD·Closed

$0.94

−4.67%

$0.94

−$0.05 (4.67%)

52W Range

7thpctl

Volume

0.41×avg

Mkt Cap

72.45MUSD

P/E

-1.6TTM

Div Yield

–ann